Technical420 Site Search

A few weeks ago, a peer-reviewed research article published in the journal PLOS ONE provided compelling data on how cannabis is impacting the pharmaceutical industry. For many years, we have written about the risks pharmaceutical companies could face with the legalization of cannabis. Numbers do not lie, and the numbers…

OTTAWA, ON, June 6, 2022 /CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development announces the launch of its new wholly owned subsidiary 'Tetra Bio-Pharma Australia Pty Ltd' ("TBP-AU"), an Australian-based research company focused on the execution of clinical trials in Australia.…

Earlier this week, the cannabis industry saw it largest acquisition in the history of the sector and this is a headline that caught the attention of major financial media firms. GW Pharmaceuticals plc (GWPH) was the target of the acquisition and it reported to have entered into a definitive agreement…

The cannabis industry made significant strides during 2016 and we think this is just the beginning…Although 2016 was a banner year for the cannabis industry, we expect 2017 to be even more significant. As we approach the end of 2016, we want to take the opportunity to highlight the most…

Agencies across the globe continue to recognize the medical benefits associated with cannabis. It is only a matter of time before this incredible plant will be legalized in the United States.From the National Cancer Institute (NCI) to the National Institute on Drug Abuse (NIDA), the medical benefits associated with cannabis…

The cannabis sector has been under pressure as the result of several factors.From an overextended industry wide rally to highly questionable cabinet nominations by president elect Donald Trump, concerns among cannabis investors have increased despite favorable state-wide election results.Although we think that some of this weakness is overdone, we expect…

This morning, Nasdaq-traded biotech firm GW Pharmaceuticals (GWPH) reported its fourth quarter earnings and the shares are trending higher in pre-market trading.The company also announced additional positive Epidiolex Phase 3 data in poster presentations at the 70th Annual Meeting of the American Epilepsy Society. The studies represented in the posters…

The biotech sector differs from other sectors of the market in the sense that it is the only industry where earnings are not the most important event for companies.Unlike other sectors, the biotech sector trades on FDA results, not earnings; and favorable results can serve as a major catalyst for…

The cannabis sector continues to produce astonishing returns and the current rally is not showing any signs of slowing down as volume continues to remain elevated.From Israel to Canada, the United States to Germany, cannabis stocks are on fire and we continue to monitor this moves closely.Capitalizing on a Cannabis…

 Cannabis stocks continue to rally and with the presidential election right around the corner, we do not expect this trend to end anytime soon.That being said, we do not recommend diving head first into the industry as the market is nothing like it was in early 2014 when you could…